# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
B of A Securities analyst Michael Cherny maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $95 to ...
Goldman Sachs analyst Nathan Rice maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $85 to $74.
Barclays analyst Andrew Mok maintains CVS Health (NYSE:CVS) with a Equal-Weight and lowers the price target from $78 to $63.
UBS analyst Kevin Caliendo downgrades CVS Health (NYSE:CVS) from Buy to Neutral and lowers the price target from $85 to $60.
Truist Securities analyst David Macdonald reiterates CVS Health (NYSE:CVS) with a Buy and lowers the price target from $90 t...
Mizuho analyst Ann Hynes maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $86 to $72.